Scarica l'app Stockscreener
47.84
1.81%
-0.88
Precedente Chiudi:
$48.72
Aprire:
$49.77
Volume 24 ore:
459.23K
Relative Volume:
0.82
Capitalizzazione di mercato:
$1.83B
Reddito:
$17.39M
Utile/perdita netta:
$-135.89M
Rapporto P/E:
-10.31
EPS:
-4.64
Flusso di cassa netto:
$-123.00M
1 W Prestazione:
-4.74%
1M Prestazione:
+2.35%
6M Prestazione:
+83.44%
1 anno Prestazione:
+58.78%
Intervallo 1D:
$47.11
$50.00
Intervallo di 1 settimana:
$47.11
$51.28
Portata 52W:
$20.08
$57.28
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Nome
Tarsus Pharmaceuticals Inc
Settore
Industria
Telefono
(949) 409-9820
Indirizzo
15440 LAGUNA CANYON ROAD, IRVINE
Confronta TARS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
47.84 | 1.83B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-20 | Iniziato | Goldman | Neutral |
| 2023-07-18 | Iniziato | William Blair | Outperform |
| 2023-05-18 | Iniziato | Guggenheim | Buy |
| 2022-08-01 | Iniziato | Barclays | Overweight |
| 2021-12-21 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-23 | Iniziato | Oppenheimer | Outperform |
| 2020-11-10 | Iniziato | BofA Securities | Buy |
| 2020-11-10 | Iniziato | Jefferies | Buy |
| 2020-11-10 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-11-10 | Iniziato | Raymond James | Strong Buy |
Mostra tutto
Tarsus Pharmaceuticals Inc Borsa (TARS) Ultime notizie
Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025 - GlobeNewswire
When Will Tarsus Share Its Latest Financial Performance? Key Date Revealed - StockTitan
Allspring Global Investments Holdings LLC Lowers Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Allspring Global Investments Holdings LLC Has $10.03 Million Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
5,825 Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Acquired by Bleakley Financial Group LLC - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by abrdn plc - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Receives "Buy" Rating from Guggenheim - MarketBeat
Where Are They Now? Tarsus Pharmaceuticals - Life Science Leader Magazine
A Bill Maher joke spotlighted Tarsus Pharmaceuticals’ crust mite fight - MM+M Online
Bleakley Financial Group LLC Purchases Shares of 5,825 Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World
Tarsus Pharmaceuticals’ (TARS) “Buy” Rating Reaffirmed at Guggenheim - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by SG Americas Securities LLC - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Reaches New 12-Month HighShould You Buy? - MarketBeat
Long Term Trading Analysis for (TARS) - news.stocktradersdaily.com
E. Ohman J or Asset Management AB Lowers Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Is Tarsus Pharmaceuticals (NASDAQ:TARS) Using Too Much Debt? - Simply Wall St
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Down 5.3%What's Next? - MarketBeat
Tarsus Pharmaceuticals Inc (TARS) Stock: Navigating Drops and Gains - The InvestChronicle
Tarsus Pharmaceuticals Inc (TARS) Shares Down Despite Recent Market Volatility - The News Heater
Jennison Associates LLC Acquires 321,552 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Janney Montgomery Scott LLC Sells 2,218 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Strong Growth Prospects and Market Expansion Drive Buy Rating for Tarsus Pharmaceuticals - TipRanks
Breakeven On The Horizon For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Yahoo Finance
BofA Adjusts Price Target on Tarsus Pharmaceuticals to $75 From $74 -February 03, 2025 at 10:36 am EST - Marketscreener.com
Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire
Exclusive Access: Tarsus Pharma's Double-Header at Elite Healthcare Investment Forums - StockTitan
Tarsus to Participate in Upcoming Investor Conferences -January 30, 2025 at 05:00 pm EST - Marketscreener.com
How To Trade (TARS) - Stock Traders Daily
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Up 9% After Analyst Upgrade - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $62.00 Price Target at Barclays - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 9% Higher After Analyst Upgrade - MarketBeat
A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts - Benzinga
Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Raised to $62.00 at Barclays - MarketBeat
Oppenheimer lifts Tarsus stock target, impressed by execution and ocular rosacea potential - MSN
Tarsus Pharmaceuticals Inc (NASDAQ: TARS): An Enticing Stock To Watch - Stocks Register
Midday Stock Roundup: Virgin Galactic down 2.3% and 87% YoY - Orange County Business Journal
Tarsus: Promising Investment, But Timing Is The Key (NASDAQ:TARS) - Seeking Alpha
Oppenheimer Increases Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $72.00 - MarketBeat
First Week of TARS March 21st Options Trading - Nasdaq
Tarsus PharmaceuticalEye Care Therapeutics - MSN
Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey
Tarsus Pharmaceuticals Inc Azioni (TARS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):